Rainbow Childrens Medicare Limited (RAINBOW) — Board Meeting | 30 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved Q1 FY26 results and promoted Anshuman Jaiswal to Chief Legal Officer
🔮 What's Next
Transaction expected completion in Q3 FY26
💡 Investor Takeaway
Revenue growth signals strong demand but dilution risk exists from ESOP issuance

Rainbow Children's Medicare approved unaudited Q1 FY26 standalone results showing 25% revenue growth to [amount not verified] and 7% PAT growth to ₹527 crore, while elevating Anshuman Jaiswal to Chief Legal Officer and designating him as Senior Management Personnel effective immediately. The board also reviewed ESOP 2025 issuance details and confirmed upcoming hospital expansion transactions.

📄 View Original Announcement (PDF)

About Rainbow Childrens Medicare Limited (RAINBOW)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹14,649.91 Cr P/E: 51.3 ROE: 17.4% ROCE: 27.1% Div Yield: 0.24%

View full RAINBOW stock details →

📡 Get AI alerts when RAINBOW files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RAINBOW — Free

📊 More RAINBOW filings

See all RAINBOW filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RAINBOW files new disclosures

Track RAINBOW filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RAINBOW — Free

Free account · 2 AI queries/day